Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats

Chalcone-1-deoxynojirimycin heterozygote (DC-5), a novel compound which was designed and synthesized in our laboratory for diabetes treatment, showed an extremely strong in vitro inhibitory activity on α-glucosidase in our previous studies. In the current research, its potential in vivo anti-diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Pin-Jian, Zeng, Jia-Cheng, Lin, Ping, Tang, Dao-Bang, Yuan, En, Tu, Yong-Gang, Zhang, Qing-Feng, Chen, Ji-Guang, Peng, Da-Yong, Yin, Zhong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658082/
https://www.ncbi.nlm.nih.gov/pubmed/36364410
http://dx.doi.org/10.3390/molecules27217583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658082/
https://www.ncbi.nlm.nih.gov/pubmed/36364410
http://dx.doi.org/10.3390/molecules27217583

Ejemplares similares